Stay updated with breaking news from Acceleration Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insilico Medicine, a clinical stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it combined two rapidly developing technologies, quantum computing and generative AI, to explore lead candidate discovery in drug development and successfully demonstrated the potential advantages of quantum generative adversarial networks in generative chemistry.
OTTAWA — Even among the $1.4 billion in grants for 11 major university research projects the federal government pledged at the end of April, the $199.5 million…
The AI Times is a weekly newsletter covering the biggest AI, machine learning, big data, and automation news from around the globe.
Hong Kong, May 04, 2023 (GLOBE NEWSWIRE) -- Frank Pun, PhD, Head of the Hong Kong R&D Center of Insilico Medicine (“Insilico”), a generative...
The Canadian government has unveiled which universities will be receiving a portion of $1.4 billion in research funding, with the single largest sum going to the University of Toronto for its work on artificial intelligence.